Search research articles
Contact Us
Filters
Showing results (41-50 of 128) with videos related to
Page
of 13
Sort By:
Surgical Endoscopy
|
November 4, 2017
Low-impact laparoscopic cholecystectomy is associated with decreased postoperative morbidity in patients with sickle cell disease
Nicola de'Angelis, Solafah Abdalla, Maria Clotilde Carra, et al.
Medicine and Science in Sports and Exercise
|
March 29, 2019
Physiological Evaluation for Endurance Exercise Prescription in Sickle Cell Disease
Laurent A Messonnier, Barnabas Gellen, Roxane Lacroix, et al.
Biomedicines
|
December 23, 2022
Case Report of Myelodysplastic Syndrome in a Sickle-Cell Disease Patient Treated with Hydroxyurea and Literature Review
Pagona Flevari, Ersi Voskaridou, Frédéric Galactéros, et al.
Blood Advances
|
January 4, 2018
Low fetal hemoglobin percentage is associated with silent brain lesions in adults with homozygous sickle cell disease
David Calvet, Titien Tuilier, Nicolas Mélé, et al.
Haematologica
|
June 22, 2010
Aggregation of mononuclear and red blood cells through an {alpha}4{beta}1-Lu/basal cell adhesion molecule interaction in sickle cell disease
Vicky Chaar, Julien Picot, Olivier Renaud, et al.
Blood
|
June 23, 2010
Decreased sickle red blood cell adhesion to laminin by hydroxyurea is associated with inhibition of Lu/BCAM protein phosphorylation
Pablo Bartolucci, Vicky Chaar, Julien Picot, et al.
American Journal of Hematology
|
July 5, 2021
Real-Life experience with hydroxyurea in patients with sickle cell disease: Results from the prospective ESCORT-HU cohort study
Mariane de Montalembert, Ersi Voskaridou, Lena Oevermann, et al.
Journal of Clinical Medicine
|
February 25, 2023
Near-Infrared Spectroscopy Demonstrates the Benefit of Erythracytapheresis in Sickle Cell Disease Adult Patients with Cerebral Vasculopathy
Suella Martino, Rym Chouk Turki, Fouzia Zouiti, et al.
Blood
|
September 1, 2009
A randomized, controlled clinical trial of ketoprofen for sickle-cell disease vaso-occlusive crises in adults
Pablo Bartolucci, Tony El Murr, Françoise Roudot-Thoraval, et al.
Plos One
|
February 12, 2025
Correction: Decreased risk of underdosing with continuous infusion versus intermittent administration of cefotaxime in patients with sickle cell disease and acute chest syndrome
Keyvan Razazi, Enora Berti, Jerome Cecchini, et al.
Page
of 13
Search research articles
Search
Showing results (41-50 of 128) with videos related to
Sort By:
Page
of 13
Surgical Endoscopy
|
November 4, 2017
Low-impact laparoscopic cholecystectomy is associated with decreased postoperative morbidity in patients with sickle cell disease
Nicola de'Angelis, Solafah Abdalla, Maria Clotilde Carra, et al.
Medicine and Science in Sports and Exercise
|
March 29, 2019
Physiological Evaluation for Endurance Exercise Prescription in Sickle Cell Disease
Laurent A Messonnier, Barnabas Gellen, Roxane Lacroix, et al.
Biomedicines
|
December 23, 2022
Case Report of Myelodysplastic Syndrome in a Sickle-Cell Disease Patient Treated with Hydroxyurea and Literature Review
Pagona Flevari, Ersi Voskaridou, Frédéric Galactéros, et al.
Blood Advances
|
January 4, 2018
Low fetal hemoglobin percentage is associated with silent brain lesions in adults with homozygous sickle cell disease
David Calvet, Titien Tuilier, Nicolas Mélé, et al.
Haematologica
|
June 22, 2010
Aggregation of mononuclear and red blood cells through an {alpha}4{beta}1-Lu/basal cell adhesion molecule interaction in sickle cell disease
Vicky Chaar, Julien Picot, Olivier Renaud, et al.
Blood
|
June 23, 2010
Decreased sickle red blood cell adhesion to laminin by hydroxyurea is associated with inhibition of Lu/BCAM protein phosphorylation
Pablo Bartolucci, Vicky Chaar, Julien Picot, et al.
American Journal of Hematology
|
July 5, 2021
Real-Life experience with hydroxyurea in patients with sickle cell disease: Results from the prospective ESCORT-HU cohort study
Mariane de Montalembert, Ersi Voskaridou, Lena Oevermann, et al.
Journal of Clinical Medicine
|
February 25, 2023
Near-Infrared Spectroscopy Demonstrates the Benefit of Erythracytapheresis in Sickle Cell Disease Adult Patients with Cerebral Vasculopathy
Suella Martino, Rym Chouk Turki, Fouzia Zouiti, et al.
Blood
|
September 1, 2009
A randomized, controlled clinical trial of ketoprofen for sickle-cell disease vaso-occlusive crises in adults
Pablo Bartolucci, Tony El Murr, Françoise Roudot-Thoraval, et al.
Plos One
|
February 12, 2025
Correction: Decreased risk of underdosing with continuous infusion versus intermittent administration of cefotaxime in patients with sickle cell disease and acute chest syndrome
Keyvan Razazi, Enora Berti, Jerome Cecchini, et al.
Page
of 13